Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Goodwill (2021 - 2026)

Immuneering's Goodwill history spans 6 years, with the latest figure at $6.7 million for Q1 2026.

  • On a quarterly basis, Goodwill changed 0.0% to $6.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $6.7 million, a 0.0% change, with the full-year FY2025 number at $6.7 million, changed 0.0% from a year prior.
  • Goodwill came in at $6.7 million for Q1 2026, roughly flat from $6.7 million in the prior quarter.
  • The five-year high for Goodwill was $6.7 million in Q1 2022, with the low at $6.7 million in Q1 2022.
  • Historically, Goodwill has averaged $6.7 million across 5 years, with a median of $6.7 million in 2022.
  • Biggest five-year swings in Goodwill: dropped 0.17% in 2022 and later changed 0.0% in 2023.
  • Year by year, Goodwill stood at $6.7 million in 2022, then changed by 0.0% to $6.7 million in 2023, then changed by 0.0% to $6.7 million in 2024, then changed by 0.0% to $6.7 million in 2025, then changed by 0.0% to $6.7 million in 2026.
  • Business Quant data shows Goodwill for IMRX at $6.7 million in Q1 2026, $6.7 million in Q4 2025, and $6.7 million in Q3 2025.